The brief
- 238 SSi Mantra systems installed in 12 countries by September 2026, with 14,103 procedures done; 188 telesurgeries by end of August.
- Q2 2026 revenue $13.9M, up 39% year on year; first-half net loss $6.2M, no long-term debt.
- FDA 510(k) filed Dec 2025, decision expected by Q1 2027; EU CE mark targeted for end-2026.
Technical approach
Built for cost
Designed and made in India, a system costs about Rs 4–5 crore, roughly a third of imported robots, so mid-size hospitals can afford one.
Separate arm carts
Three to five robotic arms sit on their own carts, so hospitals can buy what each operation needs and position arms around the patient.
Open console with 3D screen
The surgeon watches a large 3D 4K screen instead of looking into a closed viewer, so the team can see and talk more easily.
Telesurgery built in
The system is approved in India for remote surgery and proctoring, letting an expert operate or guide from another city or country.
